Vaccines (DBCOND0034954)

Identifiers

Synonyms
Vaccine / Vaccine product (medicinal product)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05099965
Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)treatment2active_not_recruiting
NCT06588530
PFAS Exposure and Immune Response to Vaccination in Adultsbasic_science4not_yet_recruiting
NCT01015703
Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy VolunteersNo drug interventionsbasic_science1completed
NCT00498303
Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008No drug interventionsprevention3completed
NCT05054621
Immunogenicity of COVID-19 Vaccine on Heterologous Scheduleprevention2completed
NCT06450379
Impact of Vaccines on Antimicrobial Microbial ResistanceNo drug interventionsNot AvailableNot Availablecompleted
NCT05752747
The Effect of Shotblocker and Cold Massage on Pain, Crying Time and Physiological Parameters in BabiesNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT05085145
Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIVNo drug interventionstreatment4unknown_status
NCT05161845
Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Liveprevention4completed
NCT00401505
Rubella Susceptibility in Multiparous WomenNo drug interventionsNot AvailableNot Availablecompleted
NCT04573205
Primary TBE Vaccination for the Elderlyprevention4not_yet_recruiting
NCT05305261
Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.No drug interventionsNot AvailableNot Availablecompleted
NCT06128928
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino CommunitiesNo drug interventionspreventionNot Availablerecruiting
NCT00172328
Antibody Response and Immune Memory 15-18 Years After HBV VaccinationpreventionNot Availableunknown_status
NCT04741828
Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in IndonesianNo drug interventionsprevention2 / 3active_not_recruiting
NCT04664309
Understanding Immunity to the COVID-19 VaccinesNo drug interventionsNot AvailableNot Availablecompleted
NCT04961385
Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose VialNo drug interventionsNot AvailableNot Availablecompleted
NCT03714737
Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in ChineseNo drug interventionsprevention3completed
NCT06136832
Pneumonia Vaccine Education Intervention StudyNo drug interventionspreventionNot Availablerecruiting
NCT05715918
Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive"No drug interventionsprevention3active_not_recruiting
NCT04460235
Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphomatreatment4recruiting
NCT05083039
Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT05046548
This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19No drug interventionsprevention1 / 2completed
NCT00560066
Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical ConditionsNo drug interventionsprevention4completed
NCT02993965
State Immunization Information Systems to Improve HPV Vaccination RatesNo drug interventionshealth_services_researchNot Availablecompleted
NCT05083065
Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 VaccineNo drug interventionsNot AvailableNot Availablecompleted
NCT04729374
COVID-19 Vaccine Induced Adaptive Immune ResponsesNo drug interventionsNot AvailableNot Availableunknown_status
NCT01961960
A Study to Evaluate Intramuscular ASP7374No drug interventionsprevention3completed
NCT03747302
HPV Message Testing and Social Media CampaignNo drug interventionshealth_services_researchNot Availablecompleted
NCT04543877
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Studybasic_science0recruiting
NCT01961947
Study of ASP7374, Cell-culture-derived Influenza VaccineNo drug interventionsprevention3completed
NCT05018078
Safety and Immunogenicity of COVID-19 Vaccination in Patients With CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04638985
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMRNo drug interventionsprevention4unknown_status
NCT00401700
Influenza Vaccine Postpartum QuestionnaireNo drug interventionsNot AvailableNot Availablecompleted
NCT05407142
An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)No drug interventionsprevention3recruiting
NCT04843917
Immunity Against COVID-19 Vaccine in Healthcare Workers in ArgentineNo drug interventionsNot AvailableNot Availablecompleted
NCT05150834
Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 VaccinesNo drug interventionsNot AvailableNot Availableunknown_status
NCT05765773
An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and OlderNo drug interventionsprevention2active_not_recruiting
NCT02366962
A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or OlderNo drug interventionsprevention3completed
NCT04969614
Safety and Immunogenicity of 2-dose Inactivated COVID-19 Vaccine in Kidney Transplant RecipientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04083950
Induction of Gut Permeability by an Oral Vaccinebasic_science0active_not_recruiting
NCT03300050
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu VaccineNo drug interventionsprevention1completed
NCT06179446
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic InfluenzaNo drug interventionsprevention1active_not_recruiting
NCT02242968
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral ProductsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05032976
Korea Comirnaty Post-marketing SurveillanceNot AvailableNot Availableactive_not_recruiting
NCT06470919
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East AfricaNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT06259487
Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.No drug interventionspreventionNot Availablerecruiting
NCT05284097
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Studyprevention2active_not_recruiting
NCT03548337
Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In IndiaNo drug interventionsprevention4completed
NCT05520970
Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1No drug interventionsprevention2terminated
NCT05593042
Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chileprevention2completed
NCT02609035
Immunization Services Model for Adult Rate ImprovementNo drug interventionshealth_services_researchNot Availablecompleted
NCT05993325
Immunogenicity and Safety of AdCLD-CoV19-1 OMI as a Booster: A COVID-19 Preventive Vaccine in Healthy Volunteersprevention3recruiting
NCT03666026
Patient Portal - Flu Reminder RecallNo drug interventionshealth_services_researchNot Availablecompleted
NCT03777865
Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In IndiaNo drug interventionsprevention4completed
NCT05586165
Effects of Prompt to Bundle COVID-19 Booster and Flu ShotNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05470582
Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Oldprevention3completed
NCT03294473
Centralized Reminder Recall - Flu RCT2No drug interventionshealth_services_researchNot Availablecompleted
NCT02692976
Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer PatientsNo drug interventionstreatment2completed
NCT05586204
Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-upNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05576623
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive VaccineNo drug interventionsprevention1 / 2completed
NCT04651790
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adultsprevention3completed
NCT04388033
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.treatment1 / 2unknown_status
NCT03294551
HPV Centralized R/R RCT #2 - New York StateNo drug interventionshealth_services_researchNot Availablecompleted
NCT05494047
Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in ChileNo drug interventionsprevention3unknown_status
NCT01672645
A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.No drug interventionstreatment1completed
NCT05401305
Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type bNo drug interventionsprevention1completed
NCT01461993
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17prevention2completed
NCT05586178
Information Provision and Consistency Framing to Increase COVID-19 Booster UptakeNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01697007
A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and MozambiqueNot Available2completed
NCT03392207
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)No drug interventionsNot AvailableNot Availablecompleted
NCT00688870
Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in TaiwanNo drug interventionsprevention3completed
NCT01306006
The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Ageprevention4completed
NCT06437834
Increasing Men's Engagement in Preventive Healthcare Through an Enhanced Cocoon Vaccination StrategyNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT00340431
Experimental Vaccine for Plasmodium Falciparum MalariaNo drug interventionstreatment1completed
NCT05457894
Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant WomenNo drug interventionsprevention3completed
NCT03776994
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle VaccineNo drug interventionsprevention1unknown_status
NCT01461980
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of AgeNo drug interventionsprevention2completed
NCT05711810
Medicine-induced Cardiac Hemodialysis on COVID-19basic_science4completed
NCT05084950
Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)No drug interventionsNot AvailableNot Availableunknown_status